A good ASX dividend share needs more than a big yield.

I think the best income shares are backed by assets, tenants, cash flows, or services that can keep supporting distributions through different market conditions.

For investors looking for income with staying power, these are two ASX dividend shares I would consider buying.

Charter Hall Long WALE REIT (ASX: CLW)

Charter Hall Long WALE REIT is one income share I would look at.

The trust owns a diversified portfolio of property assets leased to corporate and government tenants. Its focus is on long leases, which can provide investors with a clearer view of future rental income.

That is the attraction. Income investors are often looking for reliability, and long leases can help provide it. They do not remove all risk, but they can make the cash flow profile easier to understand.

I also like that the trust gives exposure to real assets. Property can be affected by interest rates, debt costs, valuations, and tenant demand. But well-leased assets can still play a useful role in an income portfolio.

The key for investors is to watch gearing, lease expiries, asset values, and distribution coverage. Property trusts can look attractive when yields are high, but balance sheet strength is still important.

For me, Charter Hall Long WALE REIT is appealing because it offers income backed by leases rather than pure economic optimism. And based on consensus estimates, it currently trades with a forward 7% dividend yield.

BWP Trust (ASX: BWP)

BWP Trust is another ASX income share I would consider.

The property group owns a portfolio of large-format retail sites, with a strong connection to Bunnings-leased properties. That gives it exposure to a tenant and retail category with a long history of relevance in Australia.

The model is simple, which I think is part of the appeal with this one.

BWP owns properties, collects rent, manages its portfolio, and pays distributions to investors. It is not trying to be a fast-moving growth stock. It is more about property income, asset quality, and long-term lease relationships.

Large-format retail sites can be valuable because they are not always easy to replace. Location, access, parking, and building suitability are important.

Interest rates and property valuations can affect the share price, and retail property still needs to be assessed carefully. But I think BWP’s tenant profile and tangible asset backing make it a useful income candidate.

Another positive is that BWP trades with a forward dividend yield of 5% based on consensus estimates.

Foolish Takeaway

Income investing can feel more comfortable when the cash flow has structure behind it.

That is what I like about these two ASX income shares. Their appeal is not just the headline yield, but the property assets, tenant relationships, and lease profiles supporting those payments.

Both still carry risks, especially around interest rates, debt, tenant demand, and property valuations. But for investors trying to build income that can last, I think these are the kinds of businesses worth considering.

The post 2 ASX dividend shares I’d buy for income with staying power appeared first on The Motley Fool Australia.

More reading

• 3 buy-rated ASX dividend shares forecast to yield 5%+ in FY 2027
• 3 ASX dividend shares with bigger yields than CBA
• Here are my 5 best ASX passive income stocks
• Charter Hall Long WALE REIT declares June 2026 distribution and DRP details
• After the Federal Budget, this is the type of property investment I’d buy in 2026

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

A $1,000 investment can be a strong starting point on the ASX.

The right exchange traded fund (ETF) can spread that money across dozens, hundreds, or even thousands of companies in a single trade.

That makes ETFs useful for investors who want diversification, long-term growth, and a simple way to get started.

With that in mind, here are three ASX ETFs that could be good options for a $1,000 investment.

Betashares Global Cybersecurity ETF (ASX: HACK)

The Betashares Global Cybersecurity ETF gives investors exposure to one of the unavoidable costs of doing business in a digital world.

Every company with customer data, online payments, cloud software, connected devices, or remote workers needs to think about cyber protection.

That is what makes cybersecurity such an interesting long-term theme. It is not tied only to one product cycle or one fashionable technology. It is linked to the basic need to keep systems, identities, money, and information safe.

The fund owns companies that sit close to that problem, including CrowdStrike (NASDAQ: CRWD), Palo Alto Networks (NASDAQ: PANW), and Fortinet (NASDAQ: FTNT).

A $1,000 investment in this ETF is essentially a bet that digital risk will keep growing and that businesses will continue spending money to defend themselves.

The fund can be volatile because it is concentrated in a specialist sector. But for investors wanting targeted exposure to cybersecurity, it could be a compelling long-term option.

VanEck Morningstar Wide Moat ETF (ASX: MOAT)

The VanEck Morningstar Wide Moat ETF takes a different approach.

This fund is built around the idea that some businesses have stronger defences than others. Those defences might come from brand strength, customer relationships, cost advantages, patents, scale, or products that are difficult to replace.

The important part is that the fund is not simply buying the largest US companies by default. It is looking for businesses that combine competitive strength with valuation discipline.

Current holdings include NXP Semiconductors (NASDAQ: NXPI), Masco Corp (NYSE: MAS), and Airbnb (NASDAQ: ABNB).

That mix is quite different from a standard market-cap weighted US index. It gives investors exposure to companies from different industries, but with a shared focus on business quality and durability.

For a $1,000 investment, this ETF could suit someone who wants US exposure with a more selective investment process behind it.

Vanguard MSCI Index International Shares ETF (ASX: VGS)

A third ASX ETF to consider is the Vanguard MSCI Index International Shares ETF.

This fund gives investors broad exposure to developed share markets outside Australia.

That can be useful because many Australian portfolios are naturally tilted toward local banks, miners, supermarkets, and dividend shares. The Vanguard MSCI Index International Shares ETF expands the opportunity by adding access to companies listed in the United States, Europe, Japan, and other major developed markets.

Its holdings include global giants such as NVIDIA (NASDAQ: NVDA), Apple (NASDAQ: AAPL), and Microsoft (NASDAQ: MSFT).

The fund is not trying to be clever or thematic. Its strength is breadth. Investors get exposure to a very large group of international companies, which can help reduce reliance on the Australian market alone.

For someone investing $1,000 and wanting a simple global foundation, it could be one of the easiest options on the ASX.

The post Which ASX ETFs are good options for a $1,000 investment? appeared first on The Motley Fool Australia.

More reading

• How I’d invest $250 a week in ASX shares to aim for $700,000
• 10 amazing ASX ETFs for the next decade
• Invest like Warren Buffett with these top ASX ETFs
• 5 high-quality ASX ETFs to buy with $5,000
• 3 world-class ASX ETFs to help build a winning portfolio

Motley Fool contributor James Mickleboro has positions in VanEck Morningstar Wide Moat ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Airbnb, Apple, BetaShares Global Cybersecurity ETF, CrowdStrike, Fortinet, Microsoft, NXP Semiconductors, and Nvidia. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Masco and Palo Alto Networks. The Motley Fool Australia has recommended Airbnb, Apple, CrowdStrike, Microsoft, Nvidia, VanEck Morningstar Wide Moat ETF, and Vanguard Msci Index International Shares ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX healthcare stock Vitrafy Life Sciences Ltd (ASX: VFY) has been one of the hottest shares in 2026. 

The company has designed and developed an innovative solution to advance cryopreservation, including smart devices, a quality management software platform, and smart packaging solutions.

Commercial success has led to significant share price gains of almost 150% in 2026 alone. 

A new report from Bell Potter suggests this is likely to continue, with the broker significantly increasing its 12-month price target. 

$30 million capital raise

Vitrafy recently raised $30 million from institutional investors at $2.60 per share.

Following this, the company announced a Share Purchase Plan (SPP). 

The company said the SPP intends to raise up to $2 million. 

The SPP provides Eligible Shareholders with the opportunity to acquire new fully paid ordinary shares in the Company (“New Shares”) at the same price as the institutional placement announced to the ASX on Friday, 12 June 2026, which raised A$30 million.

Each Eligible Shareholder may apply for up to A$30,000 worth of New Shares at the offer price of A$2.60 per New Share, irrespective of the size of their holding in Vitrafy, without incurring brokerage or transaction costs.

What is Bell Potter’s view?

Following this announcement, the team at Bell Potter provided updated guidance on this ASX healthcare stock. 

The broker largely appears constructive/bullish on the capital raise, viewing it as growth funding rather than a rescue financing.

According to the report, commercial traction is improving, with positive developments in military blood studies, animal reproduction partnerships, and growing interest from the U.S. civilian blood market.

The $32 million total raise (A$30m placement + A$2m SPP) provides enough capital to manufacture approximately 100 units and accelerate commercial deployment. 

Bell Potter estimates those units could generate around A$12 million of annual managed-service revenue, plus recurring consumable sales.

Target price increase for ASX healthcare stock

This ASX healthcare stock closed trading yesterday at $3.19 per share. 

The team at Bell Potter have now upgraded their 12-month price target to $5.15 (previously $3.00). 

It has retained its speculative buy recommendation. 

This indicates an upside potential of 61% from current levels. 

The capital raising and developments in the Red Blood Cell market have instigated a revision to our estimates, particularly from FY28 on the revenue line, where we see 175 total units being installed by FY30 which could generate $80m in annual revenue.

We still anticipate VFY reaching breakeven by FY30.

The post This ASX healthcare stock just got a big upgrade following capital raise appeared first on The Motley Fool Australia.

More reading

• Is this exciting healthcare stock a buy, hold or sell after rocketing 16% yesterday?
• What is Morgan’s updated view on this red hot ASX healthcare stock?

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.